Chris Howerton

Stock Analyst at Jefferies

(0.65)
# 2263
Out of 5,332 analysts
100
Total ratings
38.10%
Success rate
-8.40%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
ARDX Ardelyx
Maintains: Buy
11 8
3.94 103.05% 5 Jan 2, 2025
GPCR Structure Therapeuti...
Maintains: Strong Buy
50 79
25.31 212.13% 2 Sep 29, 2023
PNT POINT Biopharma Glob...
Assumes: Strong Buy
12 14
n/a n/a 3 Jul 20, 2023
MIST Milestone Pharmaceut...
Downgrades: Hold
8 4
1.29 210.08% 4 Jun 20, 2023
VERU Veru
Upgrades: Hold
1
0.5 100% 3 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
320 352
1.58 22178.48% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1 1
n/a n/a 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
720
4.83 14806.83% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
1.26 -60.32% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 10
9.71 2.99% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
8 2
2.12 -5.66% 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
2 1
n/a n/a 3 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 11
8.68 26.73% 3 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
30 20
n/a n/a 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
70 40
19.11 109.31% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
57 61
32.04 90.39% 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 90
111.92 -19.59% 3 Sep 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
870 510
n/a n/a 2 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 183
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 2
n/a n/a 2 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
24 12
4.37 174.6% 5 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
100
n/a n/a 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
101 126
1.17 10669.23% 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
1.04 1823.08% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
66
18.43 258.11% 4 Sep 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
4.58 380.35% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
1.37 1432.85% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
0.93 2265.59% 1 May 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
n/a n/a 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.19 1832.77% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
220 360
n/a n/a 3 Apr 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
40 21
14.56 44.23% 4 Apr 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
n/a n/a 2 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
6
n/a n/a 3 Dec 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 88
n/a n/a 2 Sep 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Aug 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
80 580
8.62 6628.54% 2 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
63 60
1.45 4037.93% 1 Aug 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16
70.93 -77.44% 2 Aug 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
42.01 -35.73% 1 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
0.1 23900% 1 May 26, 2020